Storage medium of platelet transfusions and the risk of transfusion-transmitted bacterial infections

Aukje L Kreuger1,2, Rutger A Middelburg1,2, Jean-Louis H Kerkhoffs1,3

  • 1Center for Clinical Transfusion Research, Sanquin Research, Leiden University Medical Center, Leiden, the Netherlands.

Transfusion
|February 2, 2017
PubMed
Abstract

Insights

Transfusion-transmitted bacterial infections (TTBIs) are a significant risk. Platelet concentrates stored in platelet additive solution (PAS) showed a fourfold higher incidence of TTBIs compared to those stored in plasma.

Area of Science:

  • Transfusion Medicine
  • Microbiology
  • Infectious Diseases

Background:

  • Transfusion-transmitted bacterial infections (TTBIs) represent a critical risk associated with platelet (PLT) concentrate transfusions.
  • The storage medium significantly impacts bacterial proliferation and the efficacy of bacterial contamination screening methods.

Purpose of the Study:

  • To quantitatively assess the relationship between PLT concentrate storage media and the occurrence of TTBIs.
  • To compare TTBI incidence across different storage media in the Netherlands.

Main Methods:

  • Retrospective analysis of all reported TTBI cases following PLT concentrate transfusion in the Netherlands (2003-2014).
  • Comparison of storage media (platelet additive solution [PAS] vs. plasma) for TTBI cases against all produced PLT concentrates.
  • Calculation of relative risk and incidence rates for TTBIs based on storage medium.

Main Results:

  • Fourteen TTBI cases were identified; 57.1% involved PLT concentrates stored in PAS and 42.9% in plasma.
  • PAS-stored PLT concentrates constituted 22.3% of all produced units, while plasma-stored units comprised 77.7%.
  • A 4.63-fold increased relative risk of TTBI was observed for PAS-stored PLT concentrates compared to plasma-stored ones. The incidence of TTBIs was 22.2 per million transfused buffy coat PLT concentrates.

Conclusions:

  • Transfusion of PLT concentrates stored in PAS is linked to a significantly higher incidence of TTBIs.
  • The findings suggest a need to re-evaluate storage practices for PLT concentrates to mitigate TTBI risks.

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.2K
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.7K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.3K